Literature DB >> 1618248

Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.

L A Salako1, A Sowunmi.   

Abstract

The pharmacokinetics of quinine has been studied in ten healthy adult Africans after intravenous infusion and oral ingestion of a 500 mg dose. Blood and saliva samples were collected over 48 h and quinine in plasma, red cells and saliva was determined by HPLC. Quinine was rapidly and almost completely absorbed after an oral dose, with absorption half-life of 0.53 h, a tmax of 1-3 h and a bioavailability of 88%. Analysis of the i.v. data gave an apparent volume of distribution of 3.6 l.kg-1 and a plasma clearance of 0.19 l.kg-1.h-1. The concentration-time curves for plasma, red cells and saliva had declining phases were approximately parallel, giving a similar half-life that in all three media. The half-lives after the i.v. infusion also did not different from those after oral administration. The dose was well tolerated by both methods of administration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618248     DOI: 10.1007/bf00278479

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  The safety and kinetics of intramuscular quinine in Malawian children with moderately severe falciparum malaria.

Authors:  S M Mansor; T E Taylor; C S McGrath; G Edwards; S A Ward; J J Wirima; M E Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jul-Aug       Impact factor: 2.184

2.  Pharmacokinetics of tolbutamide: prediction by concentration in saliva.

Authors:  S B Matin; S H Wan; J H Karam
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

Review 3.  Quinine and malaria: the African experience.

Authors:  L A Salako
Journal:  Acta Leiden       Date:  1987

4.  In-vitro chloroquine and mefloquine-resistant Plasmodium falciparum in Nigeria.

Authors:  L A Salako; A Fadeke Aderounmu
Journal:  Lancet       Date:  1987-03-07       Impact factor: 79.321

5.  Plasmodium falciparum infection not responding to chloroquine in Nigeria.

Authors:  O J Ekanem
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

6.  Relative bioavailability of the hydrochloride, sulphate and ethyl carbonate salts of quinine.

Authors:  A Jamaludin; M Mohamad; V Navaratnam; K Selliah; S C Tan; W H Wernsdorfer; K H Yuen
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

7.  Quinine-induced alterations in drug disposition.

Authors:  C M Berlin; J M Stackman; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

8.  Quinine disposition kinetics.

Authors:  N J White; P Chanthavanich; S Krishna; C Bunch; K Silamut
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

9.  Differences in the binding of quinine and quinidine to plasma proteins.

Authors:  G W Mihaly; M S Ching; M B Klejn; J Paull; R A Smallwood
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

10.  Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; M J Warrell; D Bunnag; T Harinasuta
Journal:  Am J Med       Date:  1982-10       Impact factor: 4.965

View more
  15 in total

1.  Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system.

Authors:  J M Hebden; C G Wilson; R C Spiller; P J Gilchrist; E Blackshaw; M E Frier; A C Perkins
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration.

Authors:  Julius O Soyinka; Cyprian O Onyeji; Sharon I Omoruyi; Adegbenga R Owolabi; Pullela V Sarma; James M Cook
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

Review 3.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Effect of dose size on the pharmacokinetics of orally administered quinine.

Authors:  A Sowunmi; L A Salako
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

5.  Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans.

Authors:  Shanna Babalonis; Aidan J Hampson; Michelle R Lofwall; Paul A Nuzzo; Sharon L Walsh
Journal:  J Clin Pharmacol       Date:  2015-07-29       Impact factor: 3.126

6.  The reproducibility of quinine bioavailability.

Authors:  G Paintaud; G Alván; O Ericsson
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 7.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

8.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

9.  Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?

Authors:  Sompon Wanwimolruk; Mary F Paine; Susan N Pusek; Paul B Watkins
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

Review 10.  Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.

Authors:  Jane Achan; Ambrose O Talisuna; Annette Erhart; Adoke Yeka; James K Tibenderana; Frederick N Baliraine; Philip J Rosenthal; Umberto D'Alessandro
Journal:  Malar J       Date:  2011-05-24       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.